BML Inc
XMUN:BMZ

Watchlist Manager
BML Inc Logo
BML Inc
XMUN:BMZ
Watchlist
Price: 20.8 EUR 0.97%
Market Cap: 810.9m EUR

Relative Value

The Relative Value of one BMZ stock under the Base Case scenario is 12.79 EUR. Compared to the current market price of 20.8 EUR, BML Inc is Overvalued by 39%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BMZ Relative Value
Base Case
12.79 EUR
Overvaluation 39%
Relative Value
Price
Worst Case
Base Case
Best Case

Multiples Across Competitors

BMZ Competitors Multiples
BML Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
BML Inc
XMUN:BMZ
144.9B EUR 1 20.3 4.3 7.9
US
CVS Health Corp
NYSE:CVS
103.5B USD 0.3 220.7 14.3 14.3
US
Cigna Corp
NYSE:CI
73.3B USD 0.3 11.9 0 0
US
Cigna Group
XMUN:CGN
62.4B EUR 0.3 11.8 8.9 11.3
DE
Fresenius SE & Co KGaA
XETRA:FRE
27B EUR 1.2 23.6 10.4 15.8
DE
Fresenius Medical Care AG
XMUN:FME
21.8B EUR 1.1 30.3 9.7 20.8
US
Laboratory Corporation of America Holdings
NYSE:LH
22.3B USD 1.6 26.1 14.1 19.7
US
Quest Diagnostics Inc
NYSE:DGX
20.5B USD 1.9 21.3 11.7 15.8
US
Guardant Health Inc
NASDAQ:GH
14.5B USD 16 -36.3 -38.1 -34.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.6B EUR 0.5 14.7 6.1 12.9
AU
Sonic Healthcare Ltd
ASX:SHL
11.3B AUD 1.2 22 16.5 16.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
JP
BML Inc
XMUN:BMZ
Average EV/EBITDA: 10.7
4.3
N/A N/A
US
CVS Health Corp
NYSE:CVS
14.3
25%
0.6
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
US
C
Cigna Group
XMUN:CGN
8.9
5%
1.8
DE
Fresenius SE & Co KGaA
XETRA:FRE
10.4
14%
0.7
DE
Fresenius Medical Care AG
XMUN:FME
9.7
10%
1
US
Laboratory Corporation of America Holdings
NYSE:LH
14.1
16%
0.9
US
Quest Diagnostics Inc
NYSE:DGX
11.7
8%
1.5
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -38.1 N/A N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
6.1
10%
0.6
AU
Sonic Healthcare Ltd
ASX:SHL
16.5
34%
0.5
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
JP
BML Inc
XMUN:BMZ
Average EV/EBIT: 15
7.9
N/A N/A
US
CVS Health Corp
NYSE:CVS
14.3
19%
0.8
US
Cigna Corp
NYSE:CI
Not Available N/A N/A
US
C
Cigna Group
XMUN:CGN
11.3
5%
2.3
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.8
20%
0.8
DE
Fresenius Medical Care AG
XMUN:FME
20.8
25%
0.8
US
Laboratory Corporation of America Holdings
NYSE:LH
19.7
27%
0.7
US
Quest Diagnostics Inc
NYSE:DGX
15.8
11%
1.4
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -34.6 N/A N/A
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12.9
25%
0.5
AU
Sonic Healthcare Ltd
ASX:SHL
16.5
11%
1.5